Costa Rica Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Costa Rica Pharmaceuticals and Healthcare Report

Costa Rica Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Costa Rica Pharmaceuticals and Healthcare Report
Published Apr 30, 2016
42 pages — Published Apr 30, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

...All information contained in this publication is copyrighted in the name of Business Monitor International Ltd, and as such no part of this publication may be reproduced, repackaged, redistributed, resold in whole or in any part, or used in any form or by any means graphic, electronic or mechanical, including photocopying, recording, taping, or by information storage or retrieval, or by any other means, without the express written consent of the publisher. ...

...BMI View: The approved loan from the World Bank will help improve the institutional management and organisation of healthcare delivery in Costa Rica s public healthcare sector, as well as enhance the financial sustainability of Costa Rica s universal health insurance scheme. This investment into the public healthcare service system s operational efficiency will increase Costa Rica s attractiveness for foreign investment over the long term. ...

...Costa Rica is ranked as the --th most attractive market to pharmaceutical investors in the Americas region. ...Costa Rica is ranked as the --th most attractive market to pharmaceutical investors in the Americas region. Costa Rica s score is below the regional average (--.-), owing predominantly to its relatively small drug market size and low market growth rate. ...Costa Rica is ranked as the --th most attractive market to pharmaceutical investors in the Americas region. Costa Rica s score is below the regional average (--.-), owing predominantly to its relatively small drug market size and low market growth rate.

...Opportunities Many treatment-naive patients for clinical trials. Improved market access through regional regulatory harmonisation. ...Improved market access through regional regulatory harmonisation. Costa Rica s Social Security System plans to allocate more than CRC-trn (USD-.-bn) of its budget towards public healthcare and pension payments over ----. Costa Rica s Social Security System plans to allocate more than CRC-trn (USD-.-bn) of its budget towards public healthcare and pension payments over ----. ...Costa Rica s Social Security System plans to allocate more than CRC-trn (USD-.-bn) of its budget towards public healthcare and pension payments over ----.

...

  
Source:
Document ID
2397-4478
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Costa Rica Pharmaceuticals and Healthcare Report" Apr 30, 2016. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Costa-Rica-Pharmaceuticals-and-Healthcare-Report-2026-1853>
  
APA:
Business Monitor International - Industry Reports. (2016). Costa Rica Pharmaceuticals and Healthcare Report Apr 30, 2016. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Costa-Rica-Pharmaceuticals-and-Healthcare-Report-2026-1853>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.